SG66466A1 - 5'-deoxy-cytidine derivatives - Google Patents

5'-deoxy-cytidine derivatives

Info

Publication number
SG66466A1
SG66466A1 SG1998001066A SG1998001066A SG66466A1 SG 66466 A1 SG66466 A1 SG 66466A1 SG 1998001066 A SG1998001066 A SG 1998001066A SG 1998001066 A SG1998001066 A SG 1998001066A SG 66466 A1 SG66466 A1 SG 66466A1
Authority
SG
Singapore
Prior art keywords
deoxy
cytidine derivatives
cytidine
derivatives
Prior art date
Application number
SG1998001066A
Other languages
English (en)
Inventor
Kazuo Hattori
Tohru Ishikawa
Hideo Ishitsuka
Yasunori Kohchi
Nobuhiro Oikawa
Nobuo Shimma
Hitomi Suda
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SG66466A1 publication Critical patent/SG66466A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SG1998001066A 1997-06-02 1998-05-15 5'-deoxy-cytidine derivatives SG66466A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97108791 1997-06-02

Publications (1)

Publication Number Publication Date
SG66466A1 true SG66466A1 (en) 1999-07-20

Family

ID=8226859

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1998001066A SG66466A1 (en) 1997-06-02 1998-05-15 5'-deoxy-cytidine derivatives

Country Status (33)

Country Link
US (2) US6114520A (cs)
JP (1) JP3081185B2 (cs)
KR (1) KR100312899B1 (cs)
CN (1) CN1197871C (cs)
AR (1) AR012878A1 (cs)
AT (1) ATE440854T1 (cs)
AU (1) AU746170B2 (cs)
BR (1) BR9801744A (cs)
CA (1) CA2237368C (cs)
CO (1) CO4940436A1 (cs)
CZ (1) CZ295706B6 (cs)
DE (2) DE69841086D1 (cs)
ES (2) ES2329428T3 (cs)
FR (1) FR2763953B1 (cs)
GB (1) GB2325931B (cs)
HR (1) HRP980290A2 (cs)
HU (1) HU227852B1 (cs)
ID (1) ID19801A (cs)
IL (1) IL124661A0 (cs)
IT (1) ITMI981196A1 (cs)
MA (1) MA26503A1 (cs)
MY (1) MY128985A (cs)
NO (1) NO316609B1 (cs)
NZ (1) NZ330360A (cs)
PE (1) PE79599A1 (cs)
PL (1) PL192832B1 (cs)
RS (1) RS50010B (cs)
RU (1) RU2238278C2 (cs)
SA (1) SA98190103B1 (cs)
SG (1) SG66466A1 (cs)
TR (1) TR199800988A3 (cs)
TW (1) TW584636B (cs)
ZA (1) ZA984478B (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030119724A1 (en) * 1995-11-22 2003-06-26 Ts`O Paul O.P. Ligands to enhance cellular uptake of biomolecules
DK1057831T3 (da) * 1999-05-26 2005-01-31 Hoffmann La Roche Fremgangsmåde til fremstilling af vinylpyrimidinderivater
CA2431839A1 (en) 2000-12-01 2002-06-06 Paul O. P. Ts'o Conjugates of glycosylated/galactosylated peptide
CN102441170A (zh) * 2004-12-03 2012-05-09 阿迪赫里克斯技术公司 与5-fu和5-fu前药组合施用dpd抑制剂的方法
US20060189893A1 (en) * 2005-01-06 2006-08-24 Diamics, Inc. Systems and methods for detecting abnormal cells
US20060161076A1 (en) * 2005-01-06 2006-07-20 Diamics, Inc. Systems and methods for collection of cell clusters
CA2658917C (en) * 2006-07-24 2014-10-21 Taiho Pharmaceutical Co., Ltd. 3'-ethynylcytidine derivative
WO2009042064A2 (en) 2007-09-21 2009-04-02 Nektar Therapeutics Al, Corporation Oligomer-nucleoside phosphate conjugates
KR101013312B1 (ko) * 2007-11-19 2011-02-09 한미홀딩스 주식회사 카페시타빈의 제조방법 및 이에 사용되는 β-아노머가강화된 트리알킬카보네이트 화합물의 제조방법
CN101469008B (zh) * 2007-12-29 2013-08-07 上海特化医药科技有限公司 卡培他滨羟基衍生物、其制备方法和用于制备卡培他滨
WO2009082844A1 (fr) * 2007-12-28 2009-07-09 Topharman Shanghai Co., Ltd Dérivé hydroxyle de la capécitabine, ses procédés de préparation et ses utilisations pour préparer la capécitabine
WO2009082846A1 (fr) * 2007-12-28 2009-07-09 Topharman Shanghai Co., Ltd. Dérivé hydroxyle de la capécitabine, ses procédés de préparation et ses utilisations pour préparer la capécitabine
WO2009094847A1 (fr) * 2007-12-28 2009-08-06 Topharman Shanghai Co., Ltd. Dérivé hydroxyle de capécitabine, procédés de préparation et d' utilisation de la capécitabine
US8637486B2 (en) 2008-03-14 2014-01-28 Retrotope, Inc. Therapeutic substances that modulate genome methylation
EP2393472B1 (en) * 2008-12-05 2019-06-05 NanoMed Holdings Pty Ltd Amphiphile prodrugs
GB0907551D0 (en) 2009-05-01 2009-06-10 Univ Dundee Treatment or prophylaxis of proliferative conditions
BR112012008951A2 (pt) * 2009-10-14 2019-09-24 Adherex Tech Inc tratamento de neurotoxidez associada com combinações de 5-fu ou seus profármacos e inibidores de dpd
CN104926890B (zh) * 2015-06-04 2018-04-03 新乡学院 一种1,2‑o‑二乙酰基‑3,5‑o‑二苯甲酰基核糖的合成方法
US11760773B2 (en) 2018-02-02 2023-09-19 Maverix Oncology, Inc. Small molecule drug conjugates of gemcitabine monophosphate
CN113321694A (zh) * 2021-06-22 2021-08-31 药康众拓(江苏)医药科技有限公司 N4-羟基胞苷衍生物及其制备方法和用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5726278B2 (cs) * 1973-03-13 1982-06-03
GB1561290A (en) * 1975-10-16 1980-02-20 Nyegaard & Co As Pyrimid - 2 - ones
US4071680A (en) * 1976-12-20 1978-01-31 Hoffmann-La Roche Inc. 5'-Deoxy-5-fluoropyrimidine nucleosides
CH633810A5 (en) * 1978-01-01 1982-12-31 Hoffmann La Roche Novel nucleosides and process for their preparation
US4328229A (en) * 1978-03-29 1982-05-04 Taiho Pharmaceutical Company Limited Anti-cancer composition for delivering 5-fluorouracil to cancer tissues
JPS5677226A (en) * 1979-11-27 1981-06-25 Taiho Yakuhin Kogyo Kk Antitumorigenic agent
DE3481172D1 (de) * 1983-10-26 1990-03-08 Sheldon B Greer Verfahren und materialien zum empfindlichmachen eines neoplastischen gewebes vor strahlung.
US5736531A (en) * 1987-10-28 1998-04-07 Pro-Neuron, Inc. Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides
CA1327358C (en) * 1987-11-17 1994-03-01 Morio Fujiu Fluoro cytidine derivatives
GB9020930D0 (en) * 1990-09-26 1990-11-07 Wellcome Found Pharmaceutical combinations
KR0148589B1 (ko) * 1991-05-27 1998-11-02 고바야시 유끼오 항종양 효과의 상승 및 종양의 치료를 위한 조성물 및 키트
DE4123520A1 (de) * 1991-07-16 1993-01-21 Inst Molekularbiologie Ak Mittel zur regeneration des blutbildes durch foerderung der leukozytenproliferation
AU671491B2 (en) * 1992-12-18 1996-08-29 F. Hoffmann-La Roche Ag N-oxycarbonyl substituted 5'-deoxy-5-fluorcytidines
TW254946B (cs) * 1992-12-18 1995-08-21 Hoffmann La Roche
AU6081294A (en) * 1993-05-14 1994-12-12 Pro-Neuron, Inc. Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
HUT73414A (en) * 1993-09-14 1996-07-29 Merrell Pharma Inc 5-(1-fluoro-vinyl)-1h-pyrimidine-2,4-dione derivatives useful as antineoplastic agents
US5476932A (en) * 1994-08-26 1995-12-19 Hoffmann-La Roche Inc. Process for producing N4-acyl-5'-deoxy-5-fluorocytidine derivatives
WO1996037214A2 (en) * 1995-05-26 1996-11-28 F. Hoffmann-La Roche Ag Compositions of interleukin and pyrimidine nucleosides

Also Published As

Publication number Publication date
JP3081185B2 (ja) 2000-08-28
HUP9801256A3 (en) 2004-03-01
CN1201037A (zh) 1998-12-09
RU2238278C2 (ru) 2004-10-20
TR199800988A2 (xx) 1998-12-21
ES2142763A1 (es) 2000-04-16
CN1197871C (zh) 2005-04-20
TW584636B (en) 2004-04-21
TR199800988A3 (tr) 1998-12-21
CA2237368C (en) 2009-03-03
MY128985A (en) 2007-03-30
YU22598A (sh) 2001-12-26
CA2237368A1 (en) 1998-12-02
CZ167598A3 (cs) 1998-12-16
FR2763953B1 (fr) 2005-01-07
NO982473L (no) 1998-12-03
CO4940436A1 (es) 2000-07-24
PL326604A1 (en) 1998-12-07
PE79599A1 (es) 1999-08-25
FR2763953A1 (fr) 1998-12-04
HU9801256D0 (en) 1998-07-28
GB9811762D0 (en) 1998-07-29
ES2329428T3 (es) 2009-11-25
AU6798598A (en) 1998-12-03
AR012878A1 (es) 2000-11-22
HRP980290A2 (en) 1999-04-30
DE69841086D1 (de) 2009-10-08
SA98190103B1 (ar) 2006-04-18
RS50010B (sr) 2008-09-29
HUP9801256A2 (hu) 1999-05-28
AU746170B2 (en) 2002-04-18
US6211166B1 (en) 2001-04-03
NO316609B1 (no) 2004-03-08
GB2325931A (en) 1998-12-09
CZ295706B6 (cs) 2005-10-12
HU227852B1 (en) 2012-05-02
DE19823484A1 (de) 1998-12-03
KR19990006547A (ko) 1999-01-25
BR9801744A (pt) 2000-03-21
ITMI981196A1 (it) 1999-11-29
ES2142763B1 (es) 2001-04-01
KR100312899B1 (ko) 2002-03-08
ID19801A (id) 1998-08-06
US6114520A (en) 2000-09-05
NZ330360A (en) 1999-03-29
ATE440854T1 (de) 2009-09-15
PL192832B1 (pl) 2006-12-29
IL124661A0 (en) 1998-12-06
MA26503A1 (fr) 2004-12-20
ZA984478B (en) 1998-12-02
GB2325931B (en) 2001-07-25
JPH10330395A (ja) 1998-12-15
NO982473D0 (no) 1998-05-29

Similar Documents

Publication Publication Date Title
PL337497A1 (en) 4"-substituted macrolyde derivatives
IL132809A0 (en) 4"-Substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
GB9702194D0 (en) Sulphonide derivatives
PL338563A1 (en) Substituted derivatives of 1,2,3,4-tetrahydronaphtalene
HUP0004234A3 (en) Dolastatin 15 derivatives
SG66466A1 (en) 5'-deoxy-cytidine derivatives
PL338429A1 (en) 2-[pyrazoyl-and triazolyl-3' -oksymethylene] phenylisoxazolones, -triazolones and -tetrazolones
HU9802807D0 (en) 1,3,8-triazo-spiro[4,5]decan-4-on derivatives
GB2321457B (en) 5-Aroylnaphthalene derivatives
IL136500A0 (en) 1,4-diazacycloheptane derivatives
GB9701628D0 (en) Imino-aza-anthracyclinone derivatives
DE69908936D1 (en) 2''-deoxyhygromycinderivate
GB9723845D0 (en) 6568471001
GB9712224D0 (en) `T' sectioned chain-ring
PL337368A1 (en) 13-dihydro-3'-azaridinoantracyclins
HUP9903369A3 (en) 8(9)-dehydroestradiol derivatives
GB9706753D0 (en) Aralkoxy-morphinan derivatives
GB9707090D0 (en) Let'see
GB9722157D0 (en) Bastlock 2000
GB9723437D0 (en) Farysoft 2000
GB9724541D0 (en) 'NOBO'joiner
ZA968977B (en) Draughtsman's case
GB9817203D0 (en) "Classiclamp"
GB9812719D0 (en) N'ousepad
GB9714541D0 (en) Saeed's chairlock